China SXT Pharmaceuticals(SXTC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SXTC China SXT Pharmaceuticals

Not Yet Opened 01-08 16:00:00 EST

1.25

-0.75

-37.50%

盘后1.42

+0.17+13.60%

19:59 EST

High6.98	Low1.21	Vol110.30M
Open2.03	D1 Closing2.00	Amplitude288.50%
Mkt Cap145.03M	Tradable Cap145.03M	Total Shares116.03M
T/O425.92M	T/O Rate95.07%	Tradable Shares116.03M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SXTC","market":"US","secType":"STK","nameCN":"China SXT Pharmaceuticals","latestPrice":1.25,"timestamp":1767906000000,"preClose":2,"halted":0,"volume":110303822,"hourTrading":{"tag":"盘后","latestPrice":1.42,"preClose":1.25,"latestTime":"19:59 EST","volume":6012163,"amount":8224324.4888,"timestamp":1767920399978},"delay":0,"floatShares":116027226,"shares":116027226,"eps":-2.321119,"marketStatus":"Not Yet Opened","change":-0.75,"latestTime":"01-08 16:00:00 EST","open":2.03,"high":6.9799,"low":1.21,"amount":425919324.6386736,"amplitude":2.88495,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.321119,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1767949200000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1546578000000,"exchange":"NASDAQ","adjPreClose":2,"preHourTrading":{"tag":"盘前","latestPrice":2.08,"preClose":2,"latestTime":"09:29 EST","volume":8374,"amount":17401.0489022,"timestamp":1767882597028},"postHourTrading":{"tag":"盘后","latestPrice":1.42,"preClose":1.25,"latestTime":"19:59 EST","volume":6012163,"amount":8224324.4888,"timestamp":1767920399978},"volumeRatio":486.076236},"requestUrl":"/m/hq/s/SXTC","defaultTab":"news","newsList":[{"id":"2602974573","title":"Why Is Penny Stock China SXT (SXTC) Up Almost 200% Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2602974573","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602974573?lang=en_us&edition=fundamental","pubTime":"2026-01-09 03:23","pubTimestamp":1767900223,"startTime":"0","endTime":"0","summary":"Shares in China SXT Pharmaceuticals ($SXTC) staged a massive rally on Thursday afternoon after the Chinese traditional medicine company launched an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-is-penny-stock-china-sxt-sxtc-up-almost-200-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-is-penny-stock-china-sxt-sxtc-up-almost-200-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009354923.USD","BK4007","BK4109","SXTC","SXT"],"gpt_icon":0},{"id":"2602011392","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2602011392","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602011392?lang=en_us&edition=fundamental","pubTime":"2026-01-09 02:56","pubTimestamp":1767898609,"startTime":"0","endTime":"0","summary":"FlyExclusive  said early Thursday it has signed an authorized dealership agreement with Starlink, becoming a certified dealer and installer for Starlink's \"high-speed, low-latency aviation connectivity system.\"Shares of FlyExclusive doubled as intraday trading volume catapulted to over 91.5 million from a daily average of about 20,000.China SXT Pharmaceuticals  unveiled an artificial intelligence initiative on Thursday, saying it aims to integrate AI-driven analytics into its product portfolio planning and market intelligence processes.Shares almost tripled as intraday trading volume advanced to over 66.1 million from a daily average of roughly 147,000.Century Therapeutics  reported a private placement in a financing round led by new investor TCGX, for initial gross proceeds of about $135 million.Shares surged 37% as intraday trading volume soared to more than 18.2 million from a daily average of about 1.36 million.Price: 6.81, Change: +3.67, Percent Change: +116.88","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FLYX","BK4008","SXTC","BK4505","BK4539","BK4007","BK4139","IPSC"],"gpt_icon":0},{"id":"2601652395","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 10:34 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2601652395","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601652395?lang=en_us&edition=fundamental","pubTime":"2026-01-08 23:34","pubTimestamp":1767886475,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 10:34 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nAQN2LGX1Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTC"],"gpt_icon":0},{"id":"2601458398","title":"China SXT announces launch of Strategic AI Insights Initiative","url":"https://stock-news.laohu8.com/highlight/detail?id=2601458398","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601458398?lang=en_us&edition=fundamental","pubTime":"2026-01-08 22:31","pubTimestamp":1767882663,"startTime":"0","endTime":"0","summary":"China SXT Pharmaceuticals (SXTC) announced the launch of a Strategic Artificial Intelligence (AI) Insights Initiative. This initiative aims to inte...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/china-sxt-announces-launch-of-strategic-ai-insights-initiative-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/china-sxt-announces-launch-of-strategic-ai-insights-initiative-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4528","BK4588","SXTC","BK4585","SXT","BK4109","AI","IE0009354923.USD","BK4587","BK4007","BK4551","BK4023","BK4543"],"gpt_icon":0},{"id":"2601602803","title":"China SXT Pharmaceuticals Announces Plans to Integrate AI Analytics for Product Portfolio Optimization, Market Analysis, and AI-Supported Clinic Deployment in Traditional Chinese Medicine Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=2601602803","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601602803?lang=en_us&edition=fundamental","pubTime":"2026-01-08 22:20","pubTimestamp":1767882012,"startTime":"0","endTime":"0","summary":"China SXT Pharmaceuticals Announces Plans to Integrate AI Analytics for Product Portfolio Optimization, Market Analysis, and AI-Supported Clinic Deployment in Traditional Chinese Medicine Sector. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China SXT Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire  on January 08, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL6KVBM4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK1191","BK4585","BK1606","SG9999014005.SGD","IE00B3QW5Z07.USD","LU2210150020.SGD","SXTC","LU2210149790.SGD","IE00B64PRP62.GBP","SG9999014013.SGD","00570","BK1515","SG9999014021.USD","BK4112","LU0314104364.USD","SG9999014039.USD","BK4007","LU2095319765.USD","IE00BKPKM429.USD","IE00BGHQF748.EUR","NDAQ"],"gpt_icon":0},{"id":"2601636075","title":"CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC AI INSIGHTS INITIATIVE TO OPTIMIZE TRADITIONAL CHINESE MEDICINE PORTFOLIO, ENHANCE MARKET ANALYSIS AND EXPLORE AI-SUPPORTED CLINIC DEPLOYMENT","url":"https://stock-news.laohu8.com/highlight/detail?id=2601636075","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601636075?lang=en_us&edition=fundamental","pubTime":"2026-01-08 22:20","pubTimestamp":1767882000,"startTime":"0","endTime":"0","summary":"TAIZHOU, China, Jan.  08, 2026  (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (\"China SXT\" or the \"Company\"), a specialty pharmaceutical company focusing on the research, developm","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/08/3215463/0/en/CHINA-SXT-PHARMACEUTICALS-INC-ANNOUNCES-STRATEGIC-AI-INSIGHTS-INITIATIVE-TO-OPTIMIZE-TRADITIONAL-CHINESE-MEDICINE-PORTFOLIO-ENHANCE-MARKET-ANALYSIS-AND-EXPLORE-AI-SUPPORTED-CLINIC-.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4543","BK4007","IE0009354923.USD","BK4023","SXT","SXTC","BK4551","BK4588","INC","BK4585","BK4109","BK4528","AI","BK4587"],"gpt_icon":0},{"id":"2555017835","title":"China SXT Pharmaceuticals Reports 48% Decrease in Net Loss for Fiscal Year Ending March 31, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2555017835","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555017835?lang=en_us&edition=fundamental","pubTime":"2025-07-31 21:28","pubTimestamp":1753968499,"startTime":"0","endTime":"0","summary":"China SXT Pharmaceuticals Inc. has released its annual report for the fiscal year ending March 31, 2025. The company, which operates through its subsidiary Taizhou Suxuantang in China, reported a significant variation in its financial performance compared to previous periods. While detailed figures for sales, revenues, and net income were not explicitly provided, the company highlighted key factors affecting its operations, such as the need to attract additional customers, increase brand awareness, and manage costs effectively. The report also mentioned the company's strategic focus on evolving markets and the associated risks and uncertainties. China SXT Pharmaceuticals continues to explore growth opportunities while navigating competitive and regulatory challenges.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purpose","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250731:nNDL8jRFDh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTC","BK4007"],"gpt_icon":0},{"id":"2555055493","title":"China SXT Pharmaceuticals Inc. Conducted Special Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2555055493","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555055493?lang=en_us&edition=fundamental","pubTime":"2025-07-29 19:48","pubTimestamp":1753789729,"startTime":"0","endTime":"0","summary":"China SXT Pharmaceuticals Inc. held a special meeting of shareholders on July 28, 2025. At the meeting, a proposal to create a new class of Class B Ordinary Shares and re-designate existing shares as Class A Ordinary Shares was approved. Additionally, amendments to the Memorandum and Articles of Association were adopted.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China SXT Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 29, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250729:nNDL4NR4Lp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTC"],"gpt_icon":0},{"id":"2551719905","title":"China SXT Pharmaceuticals Inc. to Vote on Dual Class Share Structure Proposal at Upcoming Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2551719905","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551719905?lang=en_us&edition=fundamental","pubTime":"2025-07-16 01:50","pubTimestamp":1752601819,"startTime":"0","endTime":"0","summary":"China SXT Pharmaceuticals Inc. has announced a special meeting of shareholders scheduled for July 28, 2025, at 9 a.m. EST, in Taizhou, Jiangsu, China. The primary agenda is to vote on a proposal to amend the company's memorandum and articles of association to introduce a dual class of shares. This move aims to create a new class of shares, and shareholders of record as of July 9, 2025, are eligible to vote.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China SXT Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 15, 2025, and is solely responsible for the informati","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250715:nNDL5MChmj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTC","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sxtchina.com","stockEarnings":[{"period":"1week","weight":-0.2188},{"period":"1month","weight":-0.0809},{"period":"3month","weight":-0.1543},{"period":"6month","weight":-0.2857},{"period":"1year","weight":-0.6784},{"period":"ytd","weight":-0.2188}],"compareEarnings":[{"period":"1week","weight":0.0111},{"period":"1month","weight":0.0095},{"period":"3month","weight":0.0559},{"period":"6month","weight":0.1057},{"period":"1year","weight":0.1697},{"period":"ytd","weight":0.0111}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and municipalities in China. The company was founded in 2005 and is headquartered in Taizhou, China.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.021132},{"month":2,"riseRate":0.571429,"avgChangeRate":-0.040435},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.143105},{"month":4,"riseRate":0,"avgChangeRate":-0.209851},{"month":5,"riseRate":0,"avgChangeRate":-0.220624},{"month":6,"riseRate":0.714286,"avgChangeRate":0.091345},{"month":7,"riseRate":0.142857,"avgChangeRate":-0.154141},{"month":8,"riseRate":0,"avgChangeRate":-0.184075},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.131032},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.1238},{"month":11,"riseRate":0.428571,"avgChangeRate":-0.076982},{"month":12,"riseRate":0.571429,"avgChangeRate":0.138689}],"exchange":"NASDAQ","name":"China SXT Pharmaceuticals","nameEN":"China SXT Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"China SXT Pharmaceuticals(SXTC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest China SXT Pharmaceuticals(SXTC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"China SXT Pharmaceuticals,SXTC,China SXT Pharmaceuticals股票,China SXT Pharmaceuticals股票老虎,China SXT Pharmaceuticals股票老虎国际,China SXT Pharmaceuticals行情,China SXT Pharmaceuticals股票行情,China SXT Pharmaceuticals股价,China SXT Pharmaceuticals股市,China SXT Pharmaceuticals股票价格,China SXT Pharmaceuticals股票交易,China SXT Pharmaceuticals股票购买,China SXT Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"China SXT Pharmaceuticals(SXTC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest China SXT Pharmaceuticals(SXTC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}